ZA906506B - Halogenoalkylphenyl-alcohols,-ketons and hydrates thereof - Google Patents

Halogenoalkylphenyl-alcohols,-ketons and hydrates thereof

Info

Publication number
ZA906506B
ZA906506B ZA906506A ZA906506A ZA906506B ZA 906506 B ZA906506 B ZA 906506B ZA 906506 A ZA906506 A ZA 906506A ZA 906506 A ZA906506 A ZA 906506A ZA 906506 B ZA906506 B ZA 906506B
Authority
ZA
South Africa
Prior art keywords
hydrates
alcohols
halogenoalkylphenyl
ketons
haloalkylphenyl
Prior art date
Application number
ZA906506A
Other languages
English (en)
Inventor
Sylvain Cottens
Cottens Sylvain
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA906506B publication Critical patent/ZA906506B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
ZA906506A 1989-08-16 1990-08-16 Halogenoalkylphenyl-alcohols,-ketons and hydrates thereof ZA906506B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3927049A DE3927049A1 (de) 1989-08-16 1989-08-16 Halogenalkyl-phenyl-ketone und deren hydrate, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
ZA906506B true ZA906506B (en) 1992-04-29

Family

ID=6387229

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA906506A ZA906506B (en) 1989-08-16 1990-08-16 Halogenoalkylphenyl-alcohols,-ketons and hydrates thereof

Country Status (18)

Country Link
US (1) US5166181A (xx)
EP (1) EP0413667B1 (xx)
JP (1) JPH03101643A (xx)
KR (1) KR910004539A (xx)
AT (1) ATE95166T1 (xx)
AU (1) AU632844B2 (xx)
CA (1) CA2023233A1 (xx)
CZ (1) CZ411391A3 (xx)
DE (2) DE3927049A1 (xx)
DK (1) DK0413667T3 (xx)
ES (1) ES2060127T3 (xx)
FI (1) FI904025A0 (xx)
HU (1) HUT58686A (xx)
IE (1) IE902938A1 (xx)
IL (1) IL95370A0 (xx)
NZ (1) NZ234902A (xx)
PT (1) PT94997A (xx)
ZA (1) ZA906506B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
EP0627400A1 (en) * 1993-06-04 1994-12-07 Merrell Dow Pharmaceuticals Inc. Aromatic acetylcholinesterase inhibitors
ATE224384T1 (de) * 1996-03-19 2002-10-15 Searle & Co Elektrophile ketone zur behandlung von herpesvirus-infectionen
US6673784B1 (en) * 1996-03-19 2004-01-06 G. D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
IT1304904B1 (it) * 1998-09-11 2001-04-05 Eisai Co Ltd Derivati anticolinesterasici per il trattamento delle sindromidolorose funzionali e/o organiche
JP4639042B2 (ja) * 2003-09-29 2011-02-23 富士フイルムファインケミカルズ株式会社 ハロゲン−リチウム交換反応を用いる有機化合物の製造法
EP2044937A4 (en) 2006-07-05 2010-10-27 Tianjin Hemay Bio Tech Co Ltd ANALGESIC DERIVATIVES 5,9 - METHANOCYCLO OCTA (B) PYRIDINE - 2 (1H) - ONE, PROCESS FOR PREPARING SAME AND USE THEREOF
AU2011215870B2 (en) 2010-02-09 2016-01-28 The Johns Hopkins University Methods and compositions for improving cognitive function
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
EP3827820A1 (en) 2013-03-15 2021-06-02 The Johns Hopkins University Brivaracetam for improving cognitive function
CN105142623A (zh) 2013-03-15 2015-12-09 艾吉因生物股份有限公司 用于改善认知功能的方法和组合物
CN112843005B (zh) 2015-05-22 2023-02-21 艾吉因生物股份有限公司 左乙拉西坦的延时释放药物组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2840617A (en) * 1954-10-25 1958-06-24 Shell Dev New polyols, their preparation and derivatives
DE1934130A1 (de) * 1968-07-26 1970-01-29 Boehringer Sohn Ingelheim Acylphenylalkylamine und ihre Herstellung
US3996279A (en) * 1973-01-02 1976-12-07 Gerot-Pharmazeutika Dr. Walter Otto K.G. Novel 2-amino methyl-4,6-dihalogenphenol derivatives and methods for the preparation thereof
US4211794A (en) * 1979-01-08 1980-07-08 Pfizer Inc. N,N-Disubstituted aminomethylphenylethanolamines
JPS62252737A (ja) * 1986-04-01 1987-11-04 Japan Tobacco Inc アルデヒドまたはケトンのアルコールへの還元方法
EP0432719A1 (en) * 1989-12-14 1991-06-19 Hoechst-Roussel Pharmaceuticals Incorporated Alkylamino- and alkylaminoalkyl diarylketones, a process for their preparation and their use as medicaments

Also Published As

Publication number Publication date
EP0413667B1 (de) 1993-09-29
CA2023233A1 (en) 1991-02-17
FI904025A0 (fi) 1990-08-14
PT94997A (pt) 1991-04-18
IL95370A0 (en) 1991-06-30
HUT58686A (en) 1992-03-30
JPH03101643A (ja) 1991-04-26
DK0413667T3 (da) 1993-11-08
IE902938A1 (en) 1991-02-27
EP0413667A1 (de) 1991-02-20
HU904868D0 (en) 1991-01-28
KR910004539A (ko) 1991-03-28
NZ234902A (en) 1993-01-27
AU6101590A (en) 1991-02-21
US5166181A (en) 1992-11-24
DE3927049A1 (de) 1991-02-21
AU632844B2 (en) 1993-01-14
ATE95166T1 (de) 1993-10-15
ES2060127T3 (es) 1994-11-16
CZ411391A3 (en) 1994-01-19
DE59002905D1 (de) 1993-11-04

Similar Documents

Publication Publication Date Title
CA1259998C (xx)
ZA906506B (en) Halogenoalkylphenyl-alcohols,-ketons and hydrates thereof
NZ192196A (en) 1-phenyl-2-azolyl-ethanols pharmaceutical compositions
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
JPS54138564A (en) Oxyiminootriazolyllethane*its preparation and use as bactericide
MY104508A (en) Stabilized stannous fluoride compositions for oral care
ZA874470B (en) New tetrahydrobenzothiazoles,and the preparation and use thereof
GB2112381B (en) Cyclic ether and thioether derivatives for use as diluents in sustained release compositions
DE3061646D1 (en) Deuterated isoflurane, its use as an anesthetic, and anesthetic compositions thereof
ZA86543B (en) 2-alkoxycarbonylalkyl-3-oxo-5,6-diaryl-as-triazines having utility as therapeutics
HU913212D0 (en) New ergoline derivatives
IL57838A0 (en) N-cyclohexyl-n-methoxyacetamide,its preparation and its use in the preparation of o-methyl-n-cyclohexyl-2,5-dimethylfuran-3-hydroxamic acid
DE3824939A1 (de) Neue 2,2-dihalogencyclopropylhydroxyethyltriazole enthaltende antimykotische mittel
MY8500132A (en) Carboxy (phenyl or tolyc)-sulphoniumsalts their preparation and use as nati-abesity agents
IT1261660B (it) Composti dotati di caratteristiche fotocromatiche in presenza di ossigeno e metodi per la loro preparazione
IL85508A0 (en) Benzylaminoaryl-dihydropyridinelactones,their preparation and their use in medicaments
JPS5615262A (en) Dihydrobisabolene and dihydrobisabolol and their use as perfume